MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms

    H. Dafsari, J. Petry-Schmelzer, M. Strack, L. Stalinski, V. Visser-Vandewalle, A. Rizos, M. Silverdale, K. Ashkan, M. Samuel, J. Evans, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To study the long-term effects of bilateral subthalamic deep brain stimulation (STN-DBS) on Quality of Life (QoL), motor, non-motor symptoms (NMS) in patients with…
  • 2017 International Congress

    Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment

    D. Weintraub, J. Norton, D. Fredericks, B. Coate, C. Andersson, C. Ballard (Philadelphia, PA, USA)

    Objective: A planned subgroup analysis of a phase 3 study was performed to evaluate the efficacy and safety of pimavanserin (PIM) in Parkinson’s disease psychosis…
  • 2017 International Congress

    Clinical correlates of severe somnolence in Parkinson’s disease: results from an international naturalistic non-motor symptoms cohort

    R. Taddei, A. Sauerbier, M. Qamar, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To compare patients with mild and severe daytime somnolence using cut-off values from item 15 of the Parkinson’s disease (PD) sleep scale (PDSS). Background:…
  • 2017 International Congress

    Motor performance measured with the UPDRS in PD patientswith varying degrees of smell loss

    c. cox, A. Kahttab, K. Amar (Bournemouth. Dorset, United Kingdom)

    Objective: To establish whether there is a possible link between the motor symptoms, which includes RBD in PD patients in this study, who have mild/moderate…
  • 2017 International Congress

    Non-motor symptoms in a cross section of PD patients with varying degrees of smell loss

    c. cox, A. Khattab, K. Amar (Bournemouth. Dorset, United Kingdom)

    Objective: To establish whether patients with PD who have mild/moderate microsmia, severe microsmia or anosmia (as measured by the University of Pennsylvania Smell Identification Test…
  • 2017 International Congress

    Parkinson’s Disease and Urogenital Dysfunction

    N. Sözer, M. Yenice, H. Erdogan, E. Demir, I. Yiğitbaşı, V. Tuğcu, V. Yayla (Istanbul, Turkey)

    Objective: The aim of this study is to identify  the involvement of urogenital functions in PD.  Background: Urogenital dysfunction could occur  in neurological diseases due to central…
  • 2017 International Congress

    Are patients with Parkinson’s disease who have either mild to moderate microsmia, severe microsmia or anosmia clinically different?

    c. cox, A. Khattab, K. Amar (Bournemouth. Dorset, United Kingdom)

    Objective: To investigate the prevalence of loss sense of smell and its possible link with the natural history of PD. Background: Non-motor symptoms (NMS) in…
  • 2017 International Congress

    Association of Metabolic Syndrome and Change in Unified Parkinson Disease Rating Scale Scores

    M. Leehey, S. Luo, S. Sharma, A.-M. Wills, J. Bainbridge, D. Simon, J. Schneider, Y. Zhang, A. Pérez, R. Dhall, C. Christine, C. Singer, F. Cambi (Aurora, CO, USA)

    Objective: To explore the association between metabolic syndrome and Unified Parkinson Disease Rating Scale (UPDRS) scores.  Background: While studies suggest that metabolic syndrome increases the…
  • 2017 International Congress

    Subthalamic nucleus local field potential activity during the sleep-wake cycle

    A. Tekriwal, J. Thompson, A. Abosch (Aurora, CO, USA)

    Objective: Characterize changes in Subthalamic Nucleus local field potential (STN LFP) activity related to stages of the sleep-wake cycle. Background: Deep brain stimulation (DBS) devices…
  • 2017 International Congress

    Baseline risk factors of insomnia symptoms after five years of follow-up: a population-based cohort of incident Parkinson’s disease

    A. Duarte Folle, B. Ritz, K. Paul (Los Angeles, CA, USA)

    Objective: To investigate baseline risk factors of insomnia symptoms after five years of follow-up, on average, in a population-based study of Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 1387
  • 1388
  • 1389
  • 1390
  • 1391
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley